ClinicalTrials.gg
CompletedNCT04118283CPSMIUpdated Oct 29, 2026Results posted

Assessment and Treatment for Chronic Pain in Veterans With Serious Mental Illness

An interventional study of Cognitive Behavioral Therapy for Chronic Pain and Health and Wellness in Chronic Pain, Schizophrenia and Psychotic Disorders, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment

How we know

Updated Oct 29, 2026Results postedStudy documents posted+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
47
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 57 studies in Chronic Pain by VA Office of Research and Development — 14 open to participants now, 15 under way, none of them phase 3. Chronic Pain · VA Office of Research and Development.

Enrollment
35th of 53
47 · median 126
Started
2021
with 7 others
No phase
44 of 57
10 open now
Registered
26th of 57
by date

Among the 57 studies in Chronic Pain by VA Office of Research and Development, this one is the 35th largest by enrollment of the 53 interventional ones that give a count, is one of 8 that started in 2021, is one of 44 with no phase, and was the 26th registered.

Chronic Pain

3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

14 of the 57 studies in Chronic Pain by VA Office of Research and Development are open now, in 1 country. Recruiting first, the newest first:

9 more — sign in →

By country, each count listing its studies:

All 14 open studies →

Where they have run

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 57 studies in Chronic Pain by VA Office of Research and Development, or all of them as a file.
02

Study summary

Chronic pain has a highly negative impact on Veterans, especially those with serious mental illness (SMI). Chronic pain leads to poorer mental health and physical functioning, and represents a critical obstacle to rehabilitation and recovery. Despite known high prevalence rates of chronic pain in SMI populations, there is little research to: a) evaluate nonpharmacological pain management strategies in this population, and b) examine directional relations between chronic pain and SMI symptoms. This study aims to address research and clinical gaps by: a) testing the feasibility and acceptability of Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) - a VA evidence-based psychotherapy for chronic pain - in Veterans with SMI, and b) better assessing the complex relation between chronic pain and psychiatric symptoms and their impact on functioning. Results from this study will inform us as to whether CBT-CP is feasible to implement, acceptable to Veterans with SMI, and worth examining in its standard or in an optimized form in a larger clinical trial.

Read the detailed description

This research study will address critical gaps in our understanding and management of chronic musculoskeletal pain in Veterans with serious mental illness (SMI), addressing the following aims:

Aim 1: Complete a pilot randomized controlled trial (RCT) with 45 Veterans with co-occurring SMI and chronic musculoskeletal pain to examine feasibility and acceptability of CBT-CP and preliminarily evaluate participant responses to intervention.

Aim 1a (Primary): Determine feasibility by demonstrating adequate rates of recruitment and completion of and fidelity to the CBT-CP intervention as well as quality and acceptability of chosen assessments.

Aim 1b (Primary): Determine acceptability by obtaining favorable ratings from satisfaction questionnaires and interviews.

Aim 1c (Exploratory): Preliminarily evaluate participant responses to intervention by exploring changes in functioning and quality of life among Veterans randomized to the CBT-CP condition (n=30).

Aim 2: Determine the feasibility of collecting EMA data to examine the temporal relationships among mental health symptoms, pain severity, and health-related functioning. Data will be collected at baseline from the 45 Veterans in the Aim 1 RCT.

Aim 2b (Primary): Determine feasibility of this approach through adherence to the EMA call schedule and overall response rates.

Aim 2a (Exploratory): Explore relationships among mental health symptoms, pain severity, and health-related functioning captured in real time.

Aim 3: Complete a well-specified process evaluation to explore how to optimize CBT-CP for use in Veterans with SMI and chronic musculoskeletal pain in future clinical trials. This evaluation will integrate qualitative data from 15 interviews with Veterans in the CBT-CP condition, CBT-CP interventionist notes, and quantitative data from Aims 1 and 2.

03

Conditions studied

  • Chronic Pain
  • Schizophrenia
  • Psychotic Disorders
  • Bipolar Disorder
  • Affective Disorders, Psychotic

Keywords

  • Veterans
  • chronic pain
  • psychotic disorders
  • affective disorders, psychotic
  • cognitive behavioral therapy
  • ecological momentary assessment
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Have a chronic musculoskeletal pain diagnosis
  • Have a Defense and Veterans Pain Rating Scale (DVPRS) rating of 4 or greater for pain severity
  • Meet criteria for an SMI diagnosis (schizophrenia, schizoaffective disorder, bipolar disorder) per medical record
  • 18 years of age or older
  • Enrolled in outpatient programming within the VA Maryland Health Care System at time of consent/study reenrollment
  • Have regular access to a telephone
  • Capacity to sign

Exclusion criteria

Exclusion Criteria:

  • Are engaging in moderate-to-severe substance use that would impact their ability to participate and/or would require a higher level of care (as determined by treating provider)
  • Engagement in Cognitive Behavioral Therapy for Chronic Pain (CBT-CP), whether currently or in the past
  • Have a current acute pain condition or limited mobility (i.e., unable to walk one city block) that would interfere with their ability to engage in CBT-CP interventions (e.g., activity pacing/walking program)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
47 participants (actual)

Study arms

  • Experimental
    Cognitive Behavioral Therapy for Chronic Pain

    Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) will be conducted in accordance with the Cognitive Behavioral Therapy for Chronic Pain: Therapist Manual and the VA Evidence-Based Practice (EBP) roll-out training. CBT-CP consists of a 12-session protocol, including an initial assessment session (BL assessment; Session 1), 10 content-specific sessions (pain education, goal-setting, cognitive and behavioral skill building; Sessions 2-11), and a booster session scheduled approximately one month after the final CBT-CP session (Session 12). Participants randomized to the CBT-CP condition (n = 30) will complete one 60-minute individual session per week. Each CBT-CP session will be led by a trained study interventionist using a manualized curriculum, following a basic structure including review of previous session material, introduction of new information or skills, and discussion of how to implement learned material into a home action plan.

    Behavioral: Cognitive Behavioral Therapy for Chronic Pain

  • Active comparator
    Health and Wellness

    Health \& Wellness was developed by VISN 5 MIRECC investigators and consists of psychoeducation on topics related to physical and emotional wellbeing. Its structure is similar to CBT-CP (10 weekly individual 60-minute sessions, no booster session). Each Health \& Wellness session will be led by a trained interventionist using a manualized curriculum that includes review of previous session material, introduction of new information, and discussion of a range of health-related topics (physical activity/exercise, nutrition/healthy eating, managing medications and side effects, and addictive behaviors (e.g., substance use, gambling, eating) that do not include pain. Typical sessions include discussion of the impact of the topic on overall health and well-being, identifying benefits and challenges to improving or maintaining health in that area, and strategies to address challenges in that area.

    Behavioral: Health and Wellness

Interventions

  • BehavioralCognitive Behavioral Therapy for Chronic Pain

    Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) will be conducted in accordance with the Cognitive Behavioral Therapy for Chronic Pain: Therapist Manual and the VA Evidence-Based Practice (EBP) roll-out training. CBT-CP consists of a 12-session protocol, including an initial assessment session (BL assessment; Session 1), 10 content-specific sessions (pain education, goal-setting, cognitive and behavioral skill building; Sessions 2-11), and a booster session scheduled approximately one month after the final CBT-CP session (Session 12). Participants randomized to the CBT-CP condition (n = 30) will complete one 60-minute individual session per week. Each CBT-CP session will be led by a trained study interventionist using a manualized curriculum, following a basic structure including review of previous session material, introduction of new information or skills, and discussion of how to implement learned material into a home action plan.

    Also known as: CBT-CP

  • BehavioralHealth and Wellness

    Health \& Wellness was developed by VISN 5 MIRECC investigators and consists of psychoeducation on topics related to physical and emotional wellbeing. Its structure is similar to CBT-CP (10 weekly individual 60-minute sessions, no booster session). Each Health \& Wellness session will be led by a trained interventionist using a manualized curriculum that includes review of previous session material, introduction of new information, and discussion of a range of health-related topics (physical activity/exercise, nutrition/healthy eating, managing medications and side effects, and addictive behaviors (e.g., substance use, gambling, eating) that do not include pain. Typical sessions include discussion of the impact of the topic on overall health and well-being, identifying benefits and challenges to improving or maintaining health in that area, and strategies to address challenges in that area.

    Also known as: H&W

06

What researchers measure

Primary outcomes

  1. Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Retention and Adherence

    To examine feasibility, engagement and participation in CBT-CP will be tracked across four key objectives: 1) evaluation of recruitment and suitability of eligibility criteria (# consented divided by # approached; # randomized divided by # consented); 2) retention and adherence rates based on the percent who engaged in treatment (% of randomized who attend first 3 sessions) and mean number of sessions attended and treatment dropout percentages (# who dropped out prior to completing treatment divided by # who engaged); 3) outreach efforts (mean number of reminders and outreach contacts made for each participant); and 4) the mean (and SD) number of completed CBT-CP homework assignments, assessed weekly by CBT-CP interventionists. The table below shows outcomes for objective 2a: retention and adherence rates.

    Time frame: Data will be gathered from each participant through intervention completion, an average of 11 weeks

  2. Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Treatment Completion Rates

    To examine feasibility, engagement and participation in CBT-CP will be tracked across four key objectives: 1) evaluation of recruitment and suitability of eligibility criteria (# consented divided by # approached; # randomized divided by # consented); 2) retention and adherence rates based on the percent who engaged in treatment (% of randomized who attend first 3 sessions) and mean number of sessions attended and treatment dropout percentages (# who dropped out prior to completing treatment divided by # who engaged); 3) outreach efforts (mean number of reminders and outreach contacts made for each participant); and 4) the mean (and SD) number of completed CBT-CP homework assignments, assessed weekly by CBT-CP interventionists. The table below shows outcomes for objective 2b: treatment completion rates.

    Time frame: Data will be gathered from each participant through intervention completion, an average of 11 weeks

  3. Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Mean Number of Sessions Completed

    To examine feasibility, engagement and participation in CBT-CP will be tracked across four key objectives: 1) evaluation of recruitment and suitability of eligibility criteria (# consented divided by # approached; # randomized divided by # consented); 2) retention and adherence rates based on the percent who engaged in treatment (% of randomized who attend first 3 sessions) and mean number of sessions attended and treatment dropout percentages (# who dropped out prior to completing treatment divided by # who engaged); 3) outreach efforts (mean number of reminders and outreach contacts made for each participant); and 4) the mean (and SD) number of completed CBT-CP homework assignments, assessed weekly by CBT-CP interventionists. The table below shows outcomes for objective 2c: mean number of sessions attended

    Time frame: Data will be gathered from each participant through intervention completion, an average of 11 weeks

  4. Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Mean Number of Home Practices Completed

    To examine feasibility, engagement and participation in CBT-CP will be tracked across four key objectives: 1) evaluation of recruitment and suitability of eligibility criteria (# consented divided by # approached; # randomized divided by # consented); 2) retention and adherence rates based on the percent who engaged in treatment (% of randomized who attend first 3 sessions) and mean number of sessions attended and treatment dropout percentages (# who dropped out prior to completing treatment divided by # who engaged); 3) outreach efforts (mean number of reminders and outreach contacts made for each participant); and 4) the mean (and SD) number of completed CBT-CP homework assignments, assessed weekly by CBT-CP interventionists. The table below shows outcomes for objective 4: mean number of home practice assignments completed.

    Time frame: Data will be gathered from each CBT-CP participant through intervention completion, an average of 11 weeks

  5. Participant Satisfaction Questionnaire (CSQ-8)

    Participants completed a treatment satisfaction survey at mid-treatment (\~session 5) and post-treatment (\~session 11) that included the Client Satisfaction Questionnaire-8. The CSQ-8 contains eight Likert scale items that ask about quality of service received and if services have been helpful. Average scores on the CSQ-8 range from 1 (lowest) to 4 (highest), with higher average scores indicating greater satisfaction. This measure was used to assess CBT-CP acceptability via treatment satisfaction surveys (Aim 1b). For analyses, post-treatment CSQ (week 11) was used for treatment completers; mid-point CSQ (week 5) was used for individuals who did not complete a full course of treatment.

    Time frame: Participants were invited to complete a treatment satisfaction survey at mid-treatment (~session/week 5) and post-treatment (~session/week 11), with overall assessment also reported

  6. Service Satisfaction Scale (SSS-18)

    Participants were invited to complete a treatment satisfaction survey at mid-treatment (\~session/week 5) and post-treatment (\~session/week 11) that included the Service Satisfaction Scale-18 (SSS-18).The SSS-18 has 18 items that assess practitioner manner and skill, perceived outcome, office procedures, and accessibility. An average score was calculated for each participant, ranging from 1 (lowest) to 5 (highest). This measure was used to assess CBT-CP acceptability along with the CSQ-8 (Aim 1b). For analyses, post-treatment SSS-18 (week 11) was used for treatment completers; mid-point SSS-18 (week 5) was used for individuals who did not complete a full course of treatment.

    Time frame: Participants were invited to complete a treatment satisfaction survey at mid-treatment (~session/week 5) and post-treatment (~session/week 11), with overall assessment also reported

  7. Ecological Momentary Assessment - Feasibility, Completed Surveys

    The Ecological Momentary Assessment (EMA) survey included 18 questions about pain severity, pain-related functioning (impact on stress, mood, sleep, activity; DVPRS), and SMI symptoms (depression \[PHQ-2\], mania \[ISS-A\], psychosis \[BASIS-24\]) experienced over the past hour. Pain-related items were derived from validated measures (Defense and Veterans Pain Rating Scale, pain severity and supplemental items) rated on a 0 (no pain/pain interference) to 10 (worst pain/complete interference); the sleep item was only asked once per day. Items from validated mental health symptom measures were used, but response scales were modified to yes/no format (i.e., whether person experienced the symptom in the past hour). Participants received three (3) surveys per day via text message (link to REDCap survey) for seven (7) days (21 total surveys); the first survey was delivered between 8am-12pm, the second between 12pm-4pm, and the third between 4pm-8pm.

    Time frame: One week, between consent and baseline assessment

Secondary outcomes

  1. West Haven-Yale Multidimensional Pain Inventory (WHYMPI) - Interference (Post-Treatment)

    The West Haven Yale Multidimensional Pain Inventory (WHYMPI) is a 52-item questionnaire providing a comprehensive assessment of components of the chronic pain experience that are helpful for the cognitive-behavioral conceptualization of chronic pain conditions. Each item is rated on a 7-point scale. The interference subscale (WHYMPI-INT), a 9-item scale, will be used in this study and measures the impact of pain on functioning (household chores, outdoor work, recreation activities, social activities). An average score is calculated that ranges from 0 (no interference) to 6 (extreme interference). The WHYMPI has been used with a wide range of chronic pain populations and is sensitive to change following rehabilitative interventions. The WHYMPI is used as part of the CBT-CP assessment protocol.

    Time frame: Post-treatment (approximately 12 weeks post-randomization)

  2. Pain Severity (Pain Numeric Rating Scale, PNRS) - Post-Treatment

    The Pain Numeric Rating Scale (PNRS) assesses pain severity over the past week based on a 0 (no pain) to 10 (worst pain imaginable) scale. Three items - average pain over the past week, worst pain over the past week, least pain over the past week - are averaged for an overall pain severity score. The PNRS has been used with a wide range of chronic pain populations and is sensitive to change following rehabilitative interventions. The PNRS is used as part of the CBT-CP assessment protocol. Participants will be assessed following completion of the study intervention, an expected average of 11 weeks

    Time frame: Post-treatment (approximately 12 weeks post-randomization)

  3. Veterans RAND 36-item Health Survey (VR-36) (Post-Treatment)

    The Veterans RAND 36-Item Health Survey (VR-36) is a 36-item questionnaire measuring health-related quality of life and 8 domains of health-related functioning (physical functioning, role limitations due to physical problems, role limitations due to emotional problems, bodily pain, general health perceptions, vitality, social functioning, and mental health). Items are scored on a 3- to 6-point scale and are summed to create each of the domain scores, ranging from 0 (worst health status) to 100 (best health status). The VR-36 demonstrated improved reliability, precision, and validity compared to the SF-36 and among persons with SMI.

    Time frame: Post-treatment (approximately 12 weeks post-randomization)

  4. World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) - Post-Treatment

    The WHODAS 2.0 is a 36-item questionnaire assessing health and disability across physical diseases and mental health disorders in both clinical and non-clinical settings and populations. Items are scored on a 5-point scale ranging from 0 (no difficulty) to 4 (extreme difficulty/cannot do) and are summed to create total (ranging from 0 to 144) and domain scores: cognition (ranging from 0 to 28); mobility (ranging from 0 to 20); self-care (ranging from 0 to 16); getting along with people (ranging from 0 to 20); life activities (ranging from 0 to 32); and participating in society (ranging from 0 to 32). Higher scores for each domain indicate greater disability. Psychometric properties are excellent, with high internal consistency, test-retest reliability, a stable factor structure, good concurrent validity, and good sensitivity to change.

    Time frame: Post-treatment (approximately 12 weeks post-randomization)

  5. World Health Organization Quality of Life Scale (WHOQOL-BREF) - Post-Treatment

    The World Health Organization Quality of Life Scale (WHOQOL-BREF) is a 26-item questionnaire assessing four domains of quality of life: physical health, psychological well-being, quality of social relationships, and environmental quality. Items use different anchors but are rated on a scale from 1 to 5. Mean scores are calculated for each domain and then transformed to range from 0 (poorest quality of life) to 100 (best quality of life). Psychometric properties of the WHOQOL-BREF are excellent, with demonstrated high internal consistency, discriminant validity, and construct validity for general, mental health, and physical health populations. The WHOQOL-BREF is used as part of the CBT-CP assessment protocol.

    Time frame: Post-treatment (approximately 12 weeks post-randomization)

  6. West Haven-Yale Multidimensional Pain Inventory (WHYMPI) - Interference (Follow-up)

    The West Haven Yale Multidimensional Pain Inventory (WHYMPI) is a 52-item questionnaire providing a comprehensive assessment of components of the chronic pain experience that are helpful for the cognitive-behavioral conceptualization of chronic pain conditions. Each item is rated on a 7-point scale. The interference subscale will be used in this study and measures the impact of pain on functioning (household chores, outdoor work, recreation activities, social activities). An average score is calculated that ranges from 0 (no interference) to 6 (extreme interference). The WHYMPI has been used with a wide range of chronic pain populations and is sensitive to change following rehabilitative interventions. The WHYMPI is used as part of the CBT-CP assessment protocol.

    Time frame: 3-Month Follow-up (approximately 24 weeks post-randomization)

  7. Pain Severity (Pain Numeric Rating Scale, PNRS) - Follow-up

    The Pain Numeric Rating Scale (PNRS) assesses pain severity over the past week based on a 0 (no pain) to 10 (worst pain imaginable) scale. Three items - average pain over the past week, worst pain over the past week, least pain over the past week - are averaged for an overall pain severity score. The PNRS has been used with a wide range of chronic pain populations and is sensitive to change following rehabilitative interventions. The PNRS is used as part of the CBT-CP assessment protocol. Participants were assessed 3-months after completion of the study intervention, an expected average of 24 weeks post-randomization.

    Time frame: 3-Month Follow-up (approximately 24 weeks post-randomization)

  8. Veterans RAND 36-item Health Survey (VR-36) (Follow-up)

    The Veterans RAND 36-Item Health Survey (VR-36) is a 36-item questionnaire measuring health-related quality of life and 8 domains of health-related functioning (physical functioning, role limitations due to physical problems, role limitations due to emotional problems, bodily pain, general health perceptions, vitality, social functioning, and mental health). Items are scored on a 3- to 6-point scale and are summed to create each of the domain scores, ranging from 0 (worst health status) to 100 (best health status). The VR-36 demonstrated improved reliability, precision, and validity compared to the SF-36 and among persons with SMI.

    Time frame: 3-Month Follow-up (approximately 24 weeks post-randomization)

  9. World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) - Follow-up

    The WHODAS 2.0 is a 36-item questionnaire assessing health and disability across physical diseases and mental health disorders in both clinical and non-clinical settings and populations. Items are scored on a 5-point scale ranging from 0 (no difficulty) to 4 (extreme difficulty/cannot do) and are summed to create total (ranging from 0 to 144) and domain scores: cognition (ranging from 0 to 28); mobility (ranging from 0 to 20); self-care (ranging from 0 to 16); getting along with people (ranging from 0 to 20); life activities (ranging from 0 to 32); and participating in society (ranging from 0 to 32). Higher scores for each domain indicate greater disability. Psychometric properties are excellent, with high internal consistency, test-retest reliability, a stable factor structure, good concurrent validity, and good sensitivity to change.

    Time frame: 3-Month Follow-up (approximately 24 weeks post-randomization)

  10. World Health Organization Quality of Life Scale (WHOQOL-BREF) - Follow-up

    The World Health Organization Quality of Life Scale (WHOQOL-BREF) is a 26-item questionnaire assessing four domains of quality of life: physical health, psychological well-being, quality of social relationships, and environmental quality. Items use different anchors but are rated on a scale from 1 to 5. Mean scores are calculated for each domain and then transformed to range from 0 (poorest quality of life) to 100 (best quality of life). Psychometric properties of the WHOQOL-BREF are excellent, with demonstrated high internal consistency, discriminant validity, and construct validity for general, mental health, and physical health populations. The WHOQOL-BREF is used as part of the CBT-CP assessment protocol.

    Time frame: 3-Month Follow-up (approximately 24 weeks post-randomization)

07

Results

Posted Oct 29, 2026
Limitations and caveats
This was a pilot feasibility study, and power to detect effects was limited due to small sample. Therefore statistical tests (e.g., lack of between group differences) should be interpreted with caution. MCIDs for pain severity and pain interference were used rather than testing intervention effects or differential effects of CBT-CP versus Health \& Wellness.

Participant flow

Veterans within VA Maryland Health Care System (VAMHCS) were recruited for the study from March, 2021 through September, 2024 via posted study flyers, provider outreach (email, staffing meetings), and DART list/medical record screening. 248 Veterans were contacted based on initial eligibility criteria (chronic pain, serious mental illness, receiving outpatient care at VAMHCS), of which n=119 refused participation and n=69 did not meet full eligibility criteria. N=60 Veterans were eligible.

Participant flow — Overall Study
MilestoneCognitive Behavioral Therapy for Chronic PainHealth and Wellness
Started2613
Completed post assessment179
Completed 3-month follow-up assessment208
Completed147
Not completed126
Withdrew: Lost to follow-up73
Withdrew: Withdrawal by subject53

Outcome measures

PrimaryCognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Retention and Adherence

To examine feasibility, engagement and participation in CBT-CP will be tracked across four key objectives: 1) evaluation of recruitment and suitability of eligibility criteria (# consented divided by # approached; # randomized divided by # consented); 2) retention and adherence rates based on the percent who engaged in treatment (% of randomized who attend first 3 sessions) and mean number of sessions attended and treatment dropout percentages (# who dropped out prior to completing treatment divided by # who engaged); 3) outreach efforts (mean number of reminders and outreach contacts made for each participant); and 4) the mean (and SD) number of completed CBT-CP homework assignments, assessed weekly by CBT-CP interventionists. The table below shows outcomes for objective 2a: retention and adherence rates.

Time frame:
Data will be gathered from each participant through intervention completion, an average of 11 weeks
Reported as:
Count of participants · Participants
Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Retention and Adherence
ParticipantsCognitive Behavioral Therapy for Chronic PainHealth and Wellness
Engaged (attended first 3 sessions)2611
Not Engaged (did not attend first 3 sessions)02
PrimaryCognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Treatment Completion Rates

To examine feasibility, engagement and participation in CBT-CP will be tracked across four key objectives: 1) evaluation of recruitment and suitability of eligibility criteria (# consented divided by # approached; # randomized divided by # consented); 2) retention and adherence rates based on the percent who engaged in treatment (% of randomized who attend first 3 sessions) and mean number of sessions attended and treatment dropout percentages (# who dropped out prior to completing treatment divided by # who engaged); 3) outreach efforts (mean number of reminders and outreach contacts made for each participant); and 4) the mean (and SD) number of completed CBT-CP homework assignments, assessed weekly by CBT-CP interventionists. The table below shows outcomes for objective 2b: treatment completion rates.

Time frame:
Data will be gathered from each participant through intervention completion, an average of 11 weeks
Reported as:
Count of participants · Participants
Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Treatment Completion Rates
ParticipantsCognitive Behavioral Therapy for Chronic PainHealth and Wellness
Completed Full Course of Treatment147
Did Not Complete Treatment126
PrimaryCognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Mean Number of Sessions Completed

To examine feasibility, engagement and participation in CBT-CP will be tracked across four key objectives: 1) evaluation of recruitment and suitability of eligibility criteria (# consented divided by # approached; # randomized divided by # consented); 2) retention and adherence rates based on the percent who engaged in treatment (% of randomized who attend first 3 sessions) and mean number of sessions attended and treatment dropout percentages (# who dropped out prior to completing treatment divided by # who engaged); 3) outreach efforts (mean number of reminders and outreach contacts made for each participant); and 4) the mean (and SD) number of completed CBT-CP homework assignments, assessed weekly by CBT-CP interventionists. The table below shows outcomes for objective 2c: mean number of sessions attended

Time frame:
Data will be gathered from each participant through intervention completion, an average of 11 weeks
Reported as:
Mean · Mean Number of Sessions
Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Mean Number of Sessions Completed
Mean Number of SessionsCognitive Behavioral Therapy for Chronic PainHealth and Wellness
Mean Number of Sessions: Overall Sample9.2 ± 3.208.4 ± 3.98
Mean Number of Sessions: Treatment Completers11.6 ± 0.8211.4 ± 0.94
Mean Number of Sessions: Treatment Non-Completers6.4 ± 2.555.0 ± 3.29
SecondaryWest Haven-Yale Multidimensional Pain Inventory (WHYMPI) - Interference (Post-Treatment)

The West Haven Yale Multidimensional Pain Inventory (WHYMPI) is a 52-item questionnaire providing a comprehensive assessment of components of the chronic pain experience that are helpful for the cognitive-behavioral conceptualization of chronic pain conditions. Each item is rated on a 7-point scale. The interference subscale (WHYMPI-INT), a 9-item scale, will be used in this study and measures the impact of pain on functioning (household chores, outdoor work, recreation activities, social activities). An average score is calculated that ranges from 0 (no interference) to 6 (extreme interference). The WHYMPI has been used with a wide range of chronic pain populations and is sensitive to change following rehabilitative interventions. The WHYMPI is used as part of the CBT-CP assessment protocol.

Time frame:
Post-treatment (approximately 12 weeks post-randomization)
Reported as:
Mean · score on a scale
West Haven-Yale Multidimensional Pain Inventory (WHYMPI) - Interference (Post-Treatment)
score on a scaleCognitive Behavioral Therapy for Chronic PainHealth and Wellness
West Haven-Yale Multidimensional Pain Inventory (WHYMPI) - Interference (Post-Treatment)3.99 ± 1.234.11 ± 1.42
SecondaryPain Severity (Pain Numeric Rating Scale, PNRS) - Post-Treatment

The Pain Numeric Rating Scale (PNRS) assesses pain severity over the past week based on a 0 (no pain) to 10 (worst pain imaginable) scale. Three items - average pain over the past week, worst pain over the past week, least pain over the past week - are averaged for an overall pain severity score. The PNRS has been used with a wide range of chronic pain populations and is sensitive to change following rehabilitative interventions. The PNRS is used as part of the CBT-CP assessment protocol. Participants will be assessed following completion of the study intervention, an expected average of 11 weeks

Time frame:
Post-treatment (approximately 12 weeks post-randomization)
Reported as:
Mean · score on a scale
Pain Severity (Pain Numeric Rating Scale, PNRS) - Post-Treatment
score on a scaleCognitive Behavioral Therapy for Chronic PainHealth and Wellness
Pain Severity (Pain Numeric Rating Scale, PNRS) - Post-Treatment4.81 ± 2.404.56 ± 2.12
SecondaryVeterans RAND 36-item Health Survey (VR-36) (Post-Treatment)

The Veterans RAND 36-Item Health Survey (VR-36) is a 36-item questionnaire measuring health-related quality of life and 8 domains of health-related functioning (physical functioning, role limitations due to physical problems, role limitations due to emotional problems, bodily pain, general health perceptions, vitality, social functioning, and mental health). Items are scored on a 3- to 6-point scale and are summed to create each of the domain scores, ranging from 0 (worst health status) to 100 (best health status). The VR-36 demonstrated improved reliability, precision, and validity compared to the SF-36 and among persons with SMI.

Time frame:
Post-treatment (approximately 12 weeks post-randomization)
Reported as:
Mean · score on a scale
Veterans RAND 36-item Health Survey (VR-36) (Post-Treatment)
score on a scaleCognitive Behavioral Therapy for Chronic PainHealth and Wellness
VR-36 Physical Composite Score (PCS)40.42 ± 8.4337.44 ± 10.91
VR-36 Mental Composite Score (MCS)41.46 ± 12.6734.31 ± 11.14
SecondaryWorld Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) - Post-Treatment

The WHODAS 2.0 is a 36-item questionnaire assessing health and disability across physical diseases and mental health disorders in both clinical and non-clinical settings and populations. Items are scored on a 5-point scale ranging from 0 (no difficulty) to 4 (extreme difficulty/cannot do) and are summed to create total (ranging from 0 to 144) and domain scores: cognition (ranging from 0 to 28); mobility (ranging from 0 to 20); self-care (ranging from 0 to 16); getting along with people (ranging from 0 to 20); life activities (ranging from 0 to 32); and participating in society (ranging from 0 to 32). Higher scores for each domain indicate greater disability. Psychometric properties are excellent, with high internal consistency, test-retest reliability, a stable factor structure, good concurrent validity, and good sensitivity to change.

Time frame:
Post-treatment (approximately 12 weeks post-randomization)
Reported as:
Mean · score on a scale
World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) - Post-Treatment
score on a scaleCognitive Behavioral Therapy for Chronic PainHealth and Wellness
WHODAS Overall Score40.94 ± 31.7553.13 ± 30.05
WHODAS - Cognition6.75 ± 5.848.88 ± 6.40
WHODAS - Mobility7.31 ± 4.477.88 ± 5.87
WHODAS - Self-Care3.56 ± 4.734.88 ± 4.26
WHODAS - Getting Along with Others4.88 ± 5.115.75 ± 4.80
WHODAS - Participating in Society10.5 ± 8.1213.75 ± 6.86
WHODAS - Life Activities7.94 ± 8.1712.00 ± 6.82
SecondaryWorld Health Organization Quality of Life Scale (WHOQOL-BREF) - Post-Treatment

The World Health Organization Quality of Life Scale (WHOQOL-BREF) is a 26-item questionnaire assessing four domains of quality of life: physical health, psychological well-being, quality of social relationships, and environmental quality. Items use different anchors but are rated on a scale from 1 to 5. Mean scores are calculated for each domain and then transformed to range from 0 (poorest quality of life) to 100 (best quality of life). Psychometric properties of the WHOQOL-BREF are excellent, with demonstrated high internal consistency, discriminant validity, and construct validity for general, mental health, and physical health populations. The WHOQOL-BREF is used as part of the CBT-CP assessment protocol.

Time frame:
Post-treatment (approximately 12 weeks post-randomization)
Reported as:
Mean · score on a scale
World Health Organization Quality of Life Scale (WHOQOL-BREF) - Post-Treatment
score on a scaleCognitive Behavioral Therapy for Chronic PainHealth and Wellness
WHOQOL-BREF Overall53.47 ± 30.2651.39 ± 17.05
WHOQOl-BREF - Physical Health53.17 ± 23.9144.44 ± 24.03
WHOQOL-BREF - Emotional Health63.80 ± 20.0847.69 ± 22.74
WHOQOL-BREF - Social Relations54.63 ± 29.1850.93 ± 18.84
WHOQOL-BREF - Environmental Health67.44 ± 24.5168.52 ± 11.45
SecondaryWest Haven-Yale Multidimensional Pain Inventory (WHYMPI) - Interference (Follow-up)

The West Haven Yale Multidimensional Pain Inventory (WHYMPI) is a 52-item questionnaire providing a comprehensive assessment of components of the chronic pain experience that are helpful for the cognitive-behavioral conceptualization of chronic pain conditions. Each item is rated on a 7-point scale. The interference subscale will be used in this study and measures the impact of pain on functioning (household chores, outdoor work, recreation activities, social activities). An average score is calculated that ranges from 0 (no interference) to 6 (extreme interference). The WHYMPI has been used with a wide range of chronic pain populations and is sensitive to change following rehabilitative interventions. The WHYMPI is used as part of the CBT-CP assessment protocol.

Time frame:
3-Month Follow-up (approximately 24 weeks post-randomization)
Reported as:
Mean · score on a scale
West Haven-Yale Multidimensional Pain Inventory (WHYMPI) - Interference (Follow-up)
score on a scaleCognitive Behavioral Therapy for Chronic PainHealth and Wellness
West Haven-Yale Multidimensional Pain Inventory (WHYMPI) - Interference (Follow-up)3.88 ± 1.193.38 ± 1.38
SecondaryPain Severity (Pain Numeric Rating Scale, PNRS) - Follow-up

The Pain Numeric Rating Scale (PNRS) assesses pain severity over the past week based on a 0 (no pain) to 10 (worst pain imaginable) scale. Three items - average pain over the past week, worst pain over the past week, least pain over the past week - are averaged for an overall pain severity score. The PNRS has been used with a wide range of chronic pain populations and is sensitive to change following rehabilitative interventions. The PNRS is used as part of the CBT-CP assessment protocol. Participants were assessed 3-months after completion of the study intervention, an expected average of 24 weeks post-randomization.

Time frame:
3-Month Follow-up (approximately 24 weeks post-randomization)
Reported as:
Mean · score on a scale
Pain Severity (Pain Numeric Rating Scale, PNRS) - Follow-up
score on a scaleCognitive Behavioral Therapy for Chronic PainHealth and Wellness
Pain Severity (Pain Numeric Rating Scale, PNRS) - Follow-up6.33 ± 1.785.96 ± 1.97
PrimaryCognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Mean Number of Home Practices Completed

To examine feasibility, engagement and participation in CBT-CP will be tracked across four key objectives: 1) evaluation of recruitment and suitability of eligibility criteria (# consented divided by # approached; # randomized divided by # consented); 2) retention and adherence rates based on the percent who engaged in treatment (% of randomized who attend first 3 sessions) and mean number of sessions attended and treatment dropout percentages (# who dropped out prior to completing treatment divided by # who engaged); 3) outreach efforts (mean number of reminders and outreach contacts made for each participant); and 4) the mean (and SD) number of completed CBT-CP homework assignments, assessed weekly by CBT-CP interventionists. The table below shows outcomes for objective 4: mean number of home practice assignments completed.

Time frame:
Data will be gathered from each CBT-CP participant through intervention completion, an average of 11 weeks
Reported as:
Mean · Percentage of Assignments Completed
Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Mean Number of Home Practices Completed
Percentage of Assignments CompletedCognitive Behavioral Therapy for Chronic Pain
Mean Percent of Completed Home Practice Assignments: Overall CBT-CP Sample73.82 ± 33.35
Mean Number of Completed Home Practice Assignments: Treatment Completers85.17 ± 17.50
Mean Number of Completed Home Practice Assignments: Treatment Non-Completers59.36 ± 43.14
Statistical analysis
  • Cognitive Behavioral Therapy for Chronic Pain · t-test, 2 sided · p = .085 · Mean difference (final values): 25.81 · 95% CI -4.15 to 55.77
PrimaryParticipant Satisfaction Questionnaire (CSQ-8)

Participants completed a treatment satisfaction survey at mid-treatment (\~session 5) and post-treatment (\~session 11) that included the Client Satisfaction Questionnaire-8. The CSQ-8 contains eight Likert scale items that ask about quality of service received and if services have been helpful. Average scores on the CSQ-8 range from 1 (lowest) to 4 (highest), with higher average scores indicating greater satisfaction. This measure was used to assess CBT-CP acceptability via treatment satisfaction surveys (Aim 1b). For analyses, post-treatment CSQ (week 11) was used for treatment completers; mid-point CSQ (week 5) was used for individuals who did not complete a full course of treatment.

Time frame:
Participants were invited to complete a treatment satisfaction survey at mid-treatment (~session/week 5) and post-treatment (~session/week 11), with overall assessment also reported
Reported as:
Mean · Average score
Participant Satisfaction Questionnaire (CSQ-8)
Average scoreCognitive Behavioral Therapy for Chronic PainHealth and Wellness
Mid-point treatment satisfaction3.73 ± 0.413.73 ± 0.48
Post-treatment treatment satisfaction0.00 ± 0.000.00 ± 0.00
Overall - latest timepoint3.88 ± 0.793.60 ± 0.48
PrimaryService Satisfaction Scale (SSS-18)

Participants were invited to complete a treatment satisfaction survey at mid-treatment (\~session/week 5) and post-treatment (\~session/week 11) that included the Service Satisfaction Scale-18 (SSS-18).The SSS-18 has 18 items that assess practitioner manner and skill, perceived outcome, office procedures, and accessibility. An average score was calculated for each participant, ranging from 1 (lowest) to 5 (highest). This measure was used to assess CBT-CP acceptability along with the CSQ-8 (Aim 1b). For analyses, post-treatment SSS-18 (week 11) was used for treatment completers; mid-point SSS-18 (week 5) was used for individuals who did not complete a full course of treatment.

Time frame:
Participants were invited to complete a treatment satisfaction survey at mid-treatment (~session/week 5) and post-treatment (~session/week 11), with overall assessment also reported
Reported as:
Mean · Average score
Service Satisfaction Scale (SSS-18)
Average scoreCognitive Behavioral Therapy for Chronic PainHealth and Wellness
Mid-treatment4.67 ± 0.454.88 ± 0.15
Post-treatment4.90 ± 0.234.63 ± 0.31
Overall - last completed timepoint4.81 ± 0.364.90 ± 0.34
SecondaryVeterans RAND 36-item Health Survey (VR-36) (Follow-up)

The Veterans RAND 36-Item Health Survey (VR-36) is a 36-item questionnaire measuring health-related quality of life and 8 domains of health-related functioning (physical functioning, role limitations due to physical problems, role limitations due to emotional problems, bodily pain, general health perceptions, vitality, social functioning, and mental health). Items are scored on a 3- to 6-point scale and are summed to create each of the domain scores, ranging from 0 (worst health status) to 100 (best health status). The VR-36 demonstrated improved reliability, precision, and validity compared to the SF-36 and among persons with SMI.

Time frame:
3-Month Follow-up (approximately 24 weeks post-randomization)
Reported as:
Mean · score on a scale
Veterans RAND 36-item Health Survey (VR-36) (Follow-up)
score on a scaleCognitive Behavioral Therapy for Chronic PainHealth and Wellness
VR-36 Physical Composite Score (PCS)36.63 ± 10.2726.81 ± 9.56
VR-36 Mental Composite Score (MCS)42.86 ± 12.0732.23 ± 12.04
SecondaryWorld Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) - Follow-up

The WHODAS 2.0 is a 36-item questionnaire assessing health and disability across physical diseases and mental health disorders in both clinical and non-clinical settings and populations. Items are scored on a 5-point scale ranging from 0 (no difficulty) to 4 (extreme difficulty/cannot do) and are summed to create total (ranging from 0 to 144) and domain scores: cognition (ranging from 0 to 28); mobility (ranging from 0 to 20); self-care (ranging from 0 to 16); getting along with people (ranging from 0 to 20); life activities (ranging from 0 to 32); and participating in society (ranging from 0 to 32). Higher scores for each domain indicate greater disability. Psychometric properties are excellent, with high internal consistency, test-retest reliability, a stable factor structure, good concurrent validity, and good sensitivity to change.

Time frame:
3-Month Follow-up (approximately 24 weeks post-randomization)
Reported as:
Mean · score on a scale
World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) - Follow-up
score on a scaleCognitive Behavioral Therapy for Chronic PainHealth and Wellness
WHODAS Overall Score47.83 ± 29.4945.87 ± 22.61
WHODAS - Cognition7.83 ± 5.477.75 ± 5.44
WHODAS - Mobility8.72 ± 5.238.38 ± 4.72
WHODAS - Self-Care3.67 ± 3.604.13 ± 4.39
WHODAS - Getting Along with Others4.83 ± 3.913.88 ± 3.48
WHODAS - Participating in Society11.94 ± 8.3212.00 ± 5.24
WHODAS - Life Activities10.83 ± 8.939.75 ± 5.06
SecondaryWorld Health Organization Quality of Life Scale (WHOQOL-BREF) - Follow-up

The World Health Organization Quality of Life Scale (WHOQOL-BREF) is a 26-item questionnaire assessing four domains of quality of life: physical health, psychological well-being, quality of social relationships, and environmental quality. Items use different anchors but are rated on a scale from 1 to 5. Mean scores are calculated for each domain and then transformed to range from 0 (poorest quality of life) to 100 (best quality of life). Psychometric properties of the WHOQOL-BREF are excellent, with demonstrated high internal consistency, discriminant validity, and construct validity for general, mental health, and physical health populations. The WHOQOL-BREF is used as part of the CBT-CP assessment protocol.

Time frame:
3-Month Follow-up (approximately 24 weeks post-randomization)
Reported as:
Mean · score on a scale
World Health Organization Quality of Life Scale (WHOQOL-BREF) - Follow-up
score on a scaleCognitive Behavioral Therapy for Chronic PainHealth and Wellness
WHOQOL-BREF Overall56.58 ± 30.7243.75 ± 23.15
WHOQOl-BREF - Physical Health50.60 ± 21.5145.98 ± 19.23
WHOQOL-BREF - Emotional Health69.91 ± 19.1053.65 ± 21.64
WHOQOL-BREF - Social Relations56.48 ± 29.8256.25 ± 11.57
WHOQOL-BREF - Environmental Health66.14 ± 24.8172.22 ± 15.43
PrimaryEcological Momentary Assessment - Feasibility, Completed Surveys

The Ecological Momentary Assessment (EMA) survey included 18 questions about pain severity, pain-related functioning (impact on stress, mood, sleep, activity; DVPRS), and SMI symptoms (depression \[PHQ-2\], mania \[ISS-A\], psychosis \[BASIS-24\]) experienced over the past hour. Pain-related items were derived from validated measures (Defense and Veterans Pain Rating Scale, pain severity and supplemental items) rated on a 0 (no pain/pain interference) to 10 (worst pain/complete interference); the sleep item was only asked once per day. Items from validated mental health symptom measures were used, but response scales were modified to yes/no format (i.e., whether person experienced the symptom in the past hour). Participants received three (3) surveys per day via text message (link to REDCap survey) for seven (7) days (21 total surveys); the first survey was delivered between 8am-12pm, the second between 12pm-4pm, and the third between 4pm-8pm.

Time frame:
One week, between consent and baseline assessment
Reported as:
Mean · Completed Surveys
Ecological Momentary Assessment - Feasibility, Completed Surveys
Completed SurveysFull Study Sample
Ecological Momentary Assessment - Feasibility, Completed Surveys14.79 ± 5.95

Adverse events

Collected over From enrollment until the end of follow-up, an average of 7 months per participant.. Non-serious events are listed at a 3% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Cognitive Behavioral Therapy for Chronic Pain0/26 (0%)0/26 (0%)0/26 (0%)
Health and Wellness0/13 (0%)0/13 (0%)0/13 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(Years)Cognitive Behavioral Therapy for Chronic PainHealth and WellnessTotal
Mean59.54 ± 11.1952.77 ± 9.9356.83 ± 11.31
Sex/Gender, Customized
Sex/Gender, Customized(Participants)Cognitive Behavioral Therapy for Chronic PainHealth and WellnessTotal
Sex/Gender — Male20525
Sex/Gender — Female5813
Sex/Gender — Other (non-binary)101
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Cognitive Behavioral Therapy for Chronic PainHealth and WellnessTotal
American Indian or Alaska Native202
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American11819
White9413
More than one race213
Unknown or Not Reported202
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Cognitive Behavioral Therapy for Chronic PainHealth and WellnessTotal
Hispanic or Latino213
Not Hispanic or Latino231235
Unknown or Not Reported101
Serious Mental Illness (SMI) diagnosis, per medical record
Serious Mental Illness (SMI) diagnosis, per medical record(Participants)Cognitive Behavioral Therapy for Chronic PainHealth and WellnessTotal
Bipolar Disorders141024
Schizophrenia Spectrum10212
MDD with Psychosis213
08

Study locations

1 site
  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
    Baltimore, Maryland 21201, United States
09

References and documents

Publications

  • Ciesinski NK, Coakley GN, Nguyen RL, Loecher AK, Harvey KP, Travaglini LE. Affect, Coping, and Self-Harm Among Veterans With Comorbid Serious Mental Illness and Chronic Pain: A Pilot Study. Psychiatr Serv. 2026 Apr 1;77(4):316-324. doi: 10.1176/appi.ps.20250130. Epub 2026 Jan 15. PubMed 41535739 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2021 to primary completion in Jul 2025, 51 months.

Results were first posted in Oct 2026, 1 year 3 months after primary completion.

Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's 51 months is above that.

Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 3, 2019
First posted
Oct 8, 2019
StartActual
Mar 18, 2021
Primary completionActual
Jul 4, 2025
CompletionActual
Aug 29, 2025
Results first posted
Oct 29, 2026
Last update
Oct 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Oct 29, 2026
Primary outcomes
2 edited, 1 time frame changed, 4 added, 1 description edited
What changed in the outcomes
  • EditedService Satisfaction Scale (SSS-3018)Time frame: Participants will be assessed following completion of the study intervention, an expected average of 10 weeks → Participants were invited to complete a treatment satisfaction survey at mid-treatment (~session/week 5) and post-treatment (~session/week 11), with overall assessment also reported
  • EditedCognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Retention and AdherenceTime frame: Data will be gathered from each participant through intervention completion, an average of 10 weeks → Data will be gathered from each participant through intervention completion, an average of 11 weeks
  • AddedCognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Treatment Completion RatesTime frame: Data will be gathered from each participant through intervention completion, an average of 11 weeks
  • AddedCognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Mean Number of Sessions CompletedTime frame: Data will be gathered from each participant through intervention completion, an average of 11 weeks
  • AddedCognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Mean Number of Home Practices CompletedTime frame: Data will be gathered from each CBT-CP participant through intervention completion, an average of 11 weeks
  • AddedEcological Momentary Assessment - Feasibility, Completed SurveysTime frame: One week, between consent and baseline assessment
  • Time frameParticipant Satisfaction Questionnaire (CSQ-8)Participants will be assessed following completion of the study intervention, an expected average of 10 weeks → Participants were invited to complete a treatment satisfaction survey at mid-treatment (~session/week 5) and post-treatment (~session/week 11), with overall assessment also reported
  • DescriptionParticipant Satisfaction Questionnaire (CSQ-8): how it is measured was reworded
Oct 29, 2026
Documents
Publications
Results publication added: Ciesinski NK, Coakley GN, Nguyen RL, Loecher AK, Harvey KP, Travaglini LE. Affect, Coping, and Self-Harm Among Veterans With Comorbid Serious Mental Illness an… PubMed 41535739 ↗
Oct 29, 2026
Secondary outcomes
8 edited, 2 added
What changed in the outcomes
  • EditedWest Haven-Yale Multidimensional Pain Inventory (WHYMPI) - Interference (Post-Treatment)Time frame: Participants will be assessed following completion of the study intervention, an expected average of 10 weeks → Post-treatment (approximately 12 weeks post-randomization)
  • EditedVeterans RAND 36-item Health Survey (VR-36) (Post-Treatment)Time frame: Participants will be assessed following completion of the study intervention, an expected average of 10 weeks → Post-treatment (approximately 12 weeks post-randomization)
  • EditedWorld Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) - Post-TreatmentTime frame: Participants will be assessed following completion of the study intervention, an expected average of 10 weeks → Post-treatment (approximately 12 weeks post-randomization)
  • EditedWorld Health Organization Quality of Life Scale (WHOQOL-BREF) - Post-TreatmentTime frame: Participants will be assessed following completion of the study intervention, an expected average of 10 weeks → Post-treatment (approximately 12 weeks post-randomization)
  • EditedWest Haven-Yale Multidimensional Pain Inventory (WHYMPI) - Interference (Follow-up)Time frame: Participants will be assessed a second time following completion of the study intervention, an expected average of 22 weeks. → 3-Month Follow-up (approximately 24 weeks post-randomization)
  • EditedVeterans RAND 36-item Health Survey (VR-36) (Follow-up)Time frame: Participants will be assessed a second time following completion of the study intervention, an expected average of 22 weeks. → 3-Month Follow-up (approximately 24 weeks post-randomization)
  • EditedWorld Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) - Follow-upTime frame: Participants will be assessed a second time following completion of the study intervention, an expected average of 22 weeks. → 3-Month Follow-up (approximately 24 weeks post-randomization)
  • EditedWorld Health Organization Quality of Life Scale (WHOQOL-BREF) - Follow-upTime frame: Participants will be assessed a second time following completion of the study intervention, an expected average of 22 weeks. → 3-Month Follow-up (approximately 24 weeks post-randomization)
  • AddedPain Severity (Pain Numeric Rating Scale, PNRS) - Post-TreatmentTime frame: Post-treatment (approximately 12 weeks post-randomization)
  • AddedPain Severity (Pain Numeric Rating Scale, PNRS) - Follow-upTime frame: 3-Month Follow-up (approximately 24 weeks post-randomization)
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    Results posted
    Publications Results publication added: Ciesinski NK, Coakley GN, Nguyen RL, Loecher AK, Harvey KP, Travaglini LE. Affect, Coping, and Self-Harm Among Veterans With Comorbid Serious Mental Illness an… PubMed 41535739 ↗
    Primary outcomes 2 edited, 1 time frame changed, 4 added, 1 description edited
    What changed in the outcomes
    • EditedService Satisfaction Scale (SSS-3018)Time frame: Participants will be assessed following completion of the study intervention, an expected average of 10 weeks → Participants were invited to complete a treatment satisfaction survey at mid-treatment (~session/week 5) and post-treatment (~session/week 11), with overall assessment also reported
    • EditedCognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Retention and AdherenceTime frame: Data will be gathered from each participant through intervention completion, an average of 10 weeks → Data will be gathered from each participant through intervention completion, an average of 11 weeks
    • AddedCognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Treatment Completion RatesTime frame: Data will be gathered from each participant through intervention completion, an average of 11 weeks
    • AddedCognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Mean Number of Sessions CompletedTime frame: Data will be gathered from each participant through intervention completion, an average of 11 weeks
    • AddedCognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Mean Number of Home Practices CompletedTime frame: Data will be gathered from each CBT-CP participant through intervention completion, an average of 11 weeks
    • AddedEcological Momentary Assessment - Feasibility, Completed SurveysTime frame: One week, between consent and baseline assessment
    • Time frameParticipant Satisfaction Questionnaire (CSQ-8)Participants will be assessed following completion of the study intervention, an expected average of 10 weeks → Participants were invited to complete a treatment satisfaction survey at mid-treatment (~session/week 5) and post-treatment (~session/week 11), with overall assessment also reported
    • DescriptionParticipant Satisfaction Questionnaire (CSQ-8): how it is measured was reworded
    Secondary outcomes 8 edited, 2 added
    What changed in the outcomes
    • EditedWest Haven-Yale Multidimensional Pain Inventory (WHYMPI) - Interference (Post-Treatment)Time frame: Participants will be assessed following completion of the study intervention, an expected average of 10 weeks → Post-treatment (approximately 12 weeks post-randomization)
    • EditedVeterans RAND 36-item Health Survey (VR-36) (Post-Treatment)Time frame: Participants will be assessed following completion of the study intervention, an expected average of 10 weeks → Post-treatment (approximately 12 weeks post-randomization)
    • EditedWorld Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) - Post-TreatmentTime frame: Participants will be assessed following completion of the study intervention, an expected average of 10 weeks → Post-treatment (approximately 12 weeks post-randomization)
    • EditedWorld Health Organization Quality of Life Scale (WHOQOL-BREF) - Post-TreatmentTime frame: Participants will be assessed following completion of the study intervention, an expected average of 10 weeks → Post-treatment (approximately 12 weeks post-randomization)
    • EditedWest Haven-Yale Multidimensional Pain Inventory (WHYMPI) - Interference (Follow-up)Time frame: Participants will be assessed a second time following completion of the study intervention, an expected average of 22 weeks. → 3-Month Follow-up (approximately 24 weeks post-randomization)
    • EditedVeterans RAND 36-item Health Survey (VR-36) (Follow-up)Time frame: Participants will be assessed a second time following completion of the study intervention, an expected average of 22 weeks. → 3-Month Follow-up (approximately 24 weeks post-randomization)
    • EditedWorld Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) - Follow-upTime frame: Participants will be assessed a second time following completion of the study intervention, an expected average of 22 weeks. → 3-Month Follow-up (approximately 24 weeks post-randomization)
    • EditedWorld Health Organization Quality of Life Scale (WHOQOL-BREF) - Follow-upTime frame: Participants will be assessed a second time following completion of the study intervention, an expected average of 22 weeks. → 3-Month Follow-up (approximately 24 weeks post-randomization)
    • AddedPain Severity (Pain Numeric Rating Scale, PNRS) - Post-TreatmentTime frame: Post-treatment (approximately 12 weeks post-randomization)
    • AddedPain Severity (Pain Numeric Rating Scale, PNRS) - Follow-upTime frame: 3-Month Follow-up (approximately 24 weeks post-randomization)
    + 2 other changes: index terms and verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT04118283
Collaborators
VA Maryland Health Care System
Responsible party
Sponsor
First posted
Oct 8, 2019
Start date
Mar 18, 2021
Primary completion
Jul 4, 2025
Completion
Aug 29, 2025
Results posted
Oct 29, 2026
Last update
Oct 29, 2026

Study contacts

Letitia Travaglini, PhD
principal investigator · Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion